Canada
· Delayed Price · Currency is CAD Profound Medical Statistics
Total Valuation
TSX:PRN has a market cap or net worth of CAD 260.75 million. The enterprise value is 189.10 million.
| Market Cap | 260.75M |
| Enterprise Value | 189.10M |
Important Dates
The last earnings date was Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:PRN has 30.04 million shares outstanding. The number of shares has increased by 16.92% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 30.04M |
| Shares Change (YoY) | +16.92% |
| Shares Change (QoQ) | +5.04% |
| Owned by Insiders (%) | 7.95% |
| Owned by Institutions (%) | 55.69% |
| Float | 27.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.99 |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.72 |
| EV / Sales | 12.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.52, with a Debt / Equity ratio of 0.08.
| Current Ratio | 10.52 |
| Quick Ratio | 9.44 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.70% and return on invested capital (ROIC) is -39.50%.
| Return on Equity (ROE) | -60.70% |
| Return on Assets (ROA) | -36.19% |
| Return on Invested Capital (ROIC) | -39.50% |
| Return on Capital Employed (ROCE) | -51.93% |
| Revenue Per Employee | 108,217 |
| Profits Per Employee | -281,851 |
| Employee Count | 142 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 0.57 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.64% in the last 52 weeks. The beta is 0.77, so TSX:PRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -15.64% |
| 50-Day Moving Average | 9.70 |
| 200-Day Moving Average | 11.06 |
| Relative Strength Index (RSI) | 33.14 |
| Average Volume (20 Days) | 8,350 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:PRN had revenue of CAD 15.37 million and -40.02 million in losses. Loss per share was -1.62.
| Revenue | 15.37M |
| Gross Profit | 10.13M |
| Operating Income | -47.57M |
| Pretax Income | -40.03M |
| Net Income | -40.02M |
| EBITDA | -46.22M |
| EBIT | -47.57M |
| Loss Per Share | -1.62 |
Balance Sheet
The company has 79.01 million in cash and 7.37 million in debt, giving a net cash position of 71.64 million or 2.38 per share.
| Cash & Cash Equivalents | 79.01M |
| Total Debt | 7.37M |
| Net Cash | 71.64M |
| Net Cash Per Share | 2.38 |
| Equity (Book Value) | 86.94M |
| Book Value Per Share | 2.89 |
| Working Capital | 89.93M |
Cash Flow
| Operating Cash Flow | -33.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.89%, with operating and profit margins of -309.57% and -260.45%.
| Gross Margin | 65.89% |
| Operating Margin | -309.57% |
| Pretax Margin | -260.47% |
| Profit Margin | -260.45% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:PRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.92% |
| Shareholder Yield | -16.92% |
| Earnings Yield | -15.35% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 16, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
TSX:PRN has an Altman Z-Score of 7.25.
| Altman Z-Score | 7.25 |
| Piotroski F-Score | n/a |